Insider Trading activities of Rhythm Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rhythm Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Rhythm Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Rhythm Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is RYTM. The reporting company's CIK number is 1649904.
The total value of stock buying since 2005 is $106,760,000.
The total value of stock sales since 2005 is $5,611,053.
The total value of stock option exercises since 2005 is $234,465.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Rhythm Pharmaceuticals, Inc. (RYTM).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-09 0 $0 31,800 $945,096 24,800 $120,702
2018-08 0 $0 0 $0 14,534 $99,993
2018-05 0 $0 151,216 $4,665,957 3,000 $13,770
2017-10 6,280,000 $106,760,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Rhythm Pharmaceuticals, Inc. insiders (RYTM)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-09-25 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Sale 31,800 29.72 945,096
2018-09-25 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Option Ex 21,800 4.59 100,062
2018-09-05 Smith Hunter C (Chief Financial Officer) Option Ex 3,000 6.88 20,640
2018-08-10 Desikan Nithya (Chief Commercial Officer) Option Ex 14,534 6.88 99,993
2018-05-22 Orbimed Capital Gp V Llc Sale 19,580 30.67 600,518
2018-05-21 Orbimed Capital Gp V Llc Sale 62,500 31.01 1,938,125
2018-05-18 Orbimed Capital Gp V Llc Sale 69,136 30.77 2,127,314
2018-05-09 Gottesdiener Keith Michael (C.E.O. and President) Option Ex 3,000 4.59 13,770
2017-10-10 Deerfield Private Design Fund Iii, L.p. Buy 355,000 17.00 6,035,000
2017-10-10 Mpm Bioventures V Llc (10% Owner) Buy 100,000 17.00 1,700,000
2017-10-10 Viswanathan Ravi (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Foley Todd (Director) Buy 100,000 17.00 1,700,000
2017-10-10 Nea 13 Gp, Ltd (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Meeker David P (Director) Buy 25,000 17.00 425,000
2017-10-10 Ipsen, S.a. (10% Owner) Buy 20,000 17.00 340,000
2017-10-10 Baskett Forest (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Sandell Scott D (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Kerins Patrick J (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Mott David M (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Barrett M James (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Isaly Samuel D (10% Owner) Buy 355,000 17.00 6,035,000
2017-10-10 Barris Peter J (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Pfizer Inc (10% Owner) Buy 40,000 17.00 680,000
2017-10-05 Baker Julian (Other) Buy 885,000 17.00 15,045,000

Insider trading activities including stock purchases, stock sales, and option exercises of RYTM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Rhythm Pharmaceuticals, Inc. (symbol RYTM, CIK number 1649904) see the Securities and Exchange Commission (SEC) website.